EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

USAG‐1 and Regenerative Dentistry, Therapeutic Implications and Future Directions: Review of the Literature

Zahra Moradi iD, Mohammadreza Karimi iD, Shirin Kolahdouz, Narges Arya, Vahid Akheshteh, Fatemeh Ayanzadeh, Yasmina Aalizadeh, Hanieh Moravvej, Marzie Keshavarzi, Amar Basri

Clinical and Experimental Dental Research · 2026-02 · 12 (1)

DOI: 10.1002/cre2.70301 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Dental Research, online erschienen am 03.02.2026. Verfasst von Zahra Moradi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Dentistry for Kids, Houston, Texas, USA. Hauptthemen laut MEDLINE: Regeneration, Bone Morphogenetic Proteins, Regenerative Endodontics, Tooth. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Uterine Sensitization‐Associated Gene 1 (USAG‐1) is a bone morphogenetic protein (BMP) antagonist vital for tooth regeneration that is expressed in kidney, gingiva, and dental tissues. Material and methods We analyzed recent studies focusing on USAG‐1 and its involvement in BMP and Wnt signaling pathways related to dental tissue repair and regeneration. Preclinical models and clinical trial data were examined to evaluate the efficacy of USAG‐1 inhibition as a therapeutic strategy. In addition, publicly available single‐cell RNA sequencing and STRING databases were analyzed to investigate the gene expression of USAG‐1 in human tissues and its protein interactions, respectively.

Results

RNA‐seq analysis confirmed that USAG‐1 is expressed in a subset of secretory cell types in kidney, jaw, and gingiva that are important for cell growth and morphogenesis. Recent studies have also demonstrated that inhibiting USAG‐1 facilitates tooth regeneration by activating BMP‐mediated morphogenesis and improving outcomes in preclinical models. Engineered monoclonal antibodies that target USAG‐1 have shown that blocking the protein product of this gene can promote third dentition and alleviate congenital tooth agenesis. Clinical trials utilizing this antibody are currently underway, with prospects for commercial applications within the next decade. Despite these advancements, challenges related to safety, specificity, and delivery mechanisms remain.

Conclusions

This review underscores the transformative potential of USAG‐1‐based therapies in regenerative dentistry, offering a paradigm shift in dental care by enabling biologically authentic tooth regeneration. However, the realization of these advancements in clinical practice requires overcoming significant barriers, including ensuring safety, optimizing delivery systems, and addressing ethical concerns. Continued interdisciplinary research is essential to fully harness the potential of USAG‐1 in regenerative dentistry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegenerationBone Morphogenetic ProteinsRegenerative EndodonticsToothHumansAnimalsWnt Signaling PathwayOdontogenesisAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

USAG‐1Wnt signaling pathwaybone morphogenetic protein (BMP) signalingregenerative dentistrytooth regeneration

Substanzen

Bone Morphogenetic ProteinsSOSTDC1 protein, humanAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Memorial Dentistry for Kids, Houston, Texas, USA.
  • School of Dentistry, Bushehr University of Medical Sciences, Bushehr, Iran.
  • Oral and Dental Disease Research Center, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
  • School of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Oral and Maxillofacial radiology, School of Dentistry, Bushehr University of Medical Sciences, Bushehr, Iran.
  • Dr. Akheshteh Oral and Maxillofacial radiology Center, Karaj, Iran.

ORCID-Profile: Zahra Moradi, Mohammadreza Karimi

Zitieren

APA

Moradi, Z., Karimi, M., Kolahdouz, S., Arya, N., Akheshteh, V., Ayanzadeh, F., Aalizadeh, Y., Moravvej, H., Keshavarzi, M., & Basri, A. (2026). USAG‐1 and Regenerative Dentistry, Therapeutic Implications and Future Directions: Review of the Literature. Clinical and Experimental Dental Research, 12(1). https://doi.org/10.1002/cre2.70301

Vancouver

Moradi Z, Karimi M, Kolahdouz S, Arya N, Akheshteh V, Ayanzadeh F, et al. USAG‐1 and Regenerative Dentistry, Therapeutic Implications and Future Directions: Review of the Literature. Clinical and Experimental Dental Research. 2026;12(1). doi:10.1002/cre2.70301

BibTeX
@article{Moradi2026,
  author = {Moradi, Zahra and Karimi, Mohammadreza and Kolahdouz, Shirin and Arya, Narges and Akheshteh, Vahid and Ayanzadeh, Fatemeh and Aalizadeh, Yasmina and Moravvej, Hanieh and Keshavarzi, Marzie and Basri, Amar},
  title = {USAG‐1 and Regenerative Dentistry, Therapeutic Implications and Future Directions: Review of the Literature},
  journal = {Clinical and Experimental Dental Research},
  year = {2026},
  volume = {12},
  number = {1},
  doi = {10.1002/cre2.70301}
}
Kostenlos starten →